Examine authors Drs. Stephanie Eisenbarth and Adam Williams weighing peanuts utilized in meals allergy testing of their lab at Northwestern College Feinberg College of Drugs. Credit score: Northwestern College
A drug already FDA-approved for bronchial asthma was discovered to almost eradicate life-threatening allergic reactions to meals allergens in mice—a breakthrough that would result in new safety for hundreds of thousands of individuals dwelling with meals allergic reactions, stories a brand new Northwestern Drugs research.
The findings are revealed within the journal Science.
The invention got here after the Northwestern scientists recognized, in mice, a beforehand unknown position for a gene referred to as DPEP1, which they discovered is crucial in regulating anaphylaxis, a fast and doubtlessly deadly allergic response.
By utilizing the bronchial asthma drug Zileuton to dam the pathway involving this gene, the scientists almost eradicated allergic responses in mice that have been beforehand extremely prone to food-induced anaphylaxis. The mice got peanut extract orally shortly after receiving Zileuton whereas the crew monitored for signs.
“It was actually shocking how well Zileuton worked,” stated co-senior research creator Dr. Stephanie Eisenbarth, the director of the Middle for Human Immunobiology and chief of the Division of Allergy and Immunology at Northwestern College Feinberg College of Drugs.
“After treatment with Zileuton, 95% of the mice showed almost no symptoms of anaphylaxis. The treatment reversed their risk from 95% susceptible to 95% protected,” added co-senior creator Dr. Adam Williams, an affiliate professor of drugs (allergy and immunology) at Feinberg.
The invention of the brand new pathway got here after a years-long ahead genetic display screen, a course of the place scientists breed generations of mice to slim down the precise genes accountable for organic variations, akin to susceptibility to meals allergy. As soon as the scientists discovered that the DPEP1 gene managed leukotrienes within the intestine—inflammatory molecules already focused by bronchial asthma medicine—they examined Zileuton, an FDA-approved drug that blocks their manufacturing.
Examine authors Dr. Stephanie Eisenbarth weighing peanuts utilized in meals allergy testing of their lab at Northwestern College Feinberg College of Drugs. Credit score: Northwestern College
‘Out-of-the-box strategy to deal with meals allergy’
Meals allergic reactions are on the rise and have an effect on greater than 33 million individuals within the U.S.—almost one in 10 individuals. But predicting an allergic particular person’s threat of anaphylaxis and stopping extreme reactions from unintentional publicity stays difficult.
Presently, there are solely two FDA-approved remedies for sure meals allergic reactions, and no remedy. One is an oral immunotherapy for peanut allergy, which does not work for everybody and may itself set off anaphylaxis. The opposite is a expensive injection (omalizumab) that additionally is not efficient for all allergic sufferers.
Zileuton might provide a brand new strategy: a easy capsule that briefly shields allergic people by blocking the physique’s anaphylactic pathway earlier than it prompts.
“This is a totally different, out-of-the-box approach to treat food allergy, unlike anything we’ve tried before,” Williams stated. “We’ve seen tragic, even fatal reactions from hidden ingredients like ground peanuts in a sauce. For parents sending their child to a birthday party, or for anyone flying where they can’t control what’s being served, this could be a powerful protective drug.”
The Northwestern crew launched a small early-stage scientific trial in July to check whether or not blocking this newly recognized pathway with Zileuton in people is as efficient because it was in mice.
Examine creator Dr. Adam Williams conducting allergy analysis. Credit score: Northwestern College
Serving to to unravel a meals allergy thriller
The findings additionally make clear a long-standing puzzle in allergy drugs: why some people check constructive for meals allergens however expertise no signs after they eat the meals.
“Let’s say you’re told you’re allergic to peanuts based on a blood test, but you’ve eaten peanuts your whole life without any problems,” Eisenbarth stated. “This pathway we discovered may be one explanation for why some of those people are protected.”
That group has been a problem for clinicians and a supply of stress for sufferers, Eisenbarth added, as a result of present diagnostic exams solely estimate allergy threat, not tolerance.
“Our findings open a whole new area for future research into how people develop food allergies in the first place, and why some react while others don’t,” she stated.
The breakthrough would not have been attainable with out long-term funding in scientific analysis, Eisenbarth stated.
“If you’d asked me five or six years ago to guess the pathway that would lead to this discovery, I never would have picked this gene or the leukotriene molecules,” she stated.
The opposite Northwestern College authors that supported the research are Danielle Jacobsen, Dr. Eli Olson, Dr. Slim Fourati, Dr. Aditi Verma, Caleb McBride, Kara Greenfield and Rebecca Krier-Burris. The work was finished in collaboration with investigators throughout the U.S. together with Laura Hoyt, Emily Siniscalco, Dr. Elise Liu, and Dr. Craig Wilen from Yale College.
The paper will seem in the identical challenge of Science with one other research, led by Dr. Ruslan Medzhitov at Yale College, that additionally found the leukotriene pathway that regulates meals allergy in mice by means of a distinct strategy.
Extra info:
Laura Hoyt et al, Cysteinyl leukotrienes stimulate intestine absorption of meals allergens and promote anaphylaxis in mice, Science (2025). DOI: 10.1126/science.adp0240
Offered by
Northwestern College
Quotation:
Bronchial asthma drug Zileuton prevents extreme meals allergy reactions in mouse research (2025, August 7)
retrieved 7 August 2025
from https://medicalxpress.com/information/2025-08-asthma-drug-zileuton-severe-food.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
